Sponsoring ISRT 2025 in Baku

‍

We’re honored to serve as a Platinum Sponsor of the 2025 International Symposium on Radiopharmaceutical Therapy (ISRT)—a leading academic forum advancing innovation in nuclear medicine.

At Nucs AI, we are redefining prostate cancer care through intelligent imaging. By combining AI-driven quantification and predictive analytics, we’re helping clinicians and researchers unlock new levels of precision in PSMA-PET/CT interpretation

‍

Meet Us in Baku | April 10–12, 2025

We’ll be showcasing our two flagship solutions:

• DeepPSMA – for automated detection, staging, and quantification of tumor burden
• SelectPSMA – for predicting response to ¹⁷⁷Lu-PSMA-617 therapy in mCRPC patients

Visit our booth to explore how our tools support standardization, research scalability, and clinically meaningful insights across the continuum of prostate cancer care

‍

Connect with Our Team

To schedule a meeting at ISRT 2025 or speak with us virtually, contact us here. We look forward to thoughtful conversations with the academic community pushing nuclear medicine forward.

‍